Table 2. Sociodemograpnic and clinical baseline characteristics in each arm of the trial.
| Control arm (151 patients) | Intervention arm (194 patients) | Declined to participate (232 patients) | Anticoagulated patientswho were not contacted (250 patients) | |
|---|---|---|---|---|
|
Sex male female |
64 (42%) 70 (58%) |
86 (44%) 99 (56%) |
102 (44%) 130 (56%) |
118 (47%) 132 (53%) |
| Age (years) | 72±10*1 | 73±10*1 | 74±11*1 | 74±10*1 |
|
Schooling < 10 years = 10 years |
98 (65%) 53 (35%) |
155 (80%) 39 (20%) |
||
|
Indication for anticoagulation, according to the patient*2 atrial fibrillation thrombosis pulmonary embolism heart valve replacement unknown |
94 (62%) 25 (17%) 13 (9%) 18 (15%) 15 (10%) |
149 (77%) (22%) (11%) 17 (9%) 2 (1%) |
||
| History of complications of anticoagulation | 16 (11%) | 15 (8%) | ||
| Fear of thrombosis | 83 (55%) | 97 (50%) | ||
| Fear of bleeding | 88 (58%) | 91 (47%) |
*1 mean ± standard deviation
*2multiple indications possible